Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Teva Pharmaceuticals USA, Inc. · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 10/12/2022
- Package NDC
- 57844-117-01
- Generic name
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
- Contact info
- 800-545-8800
- Availability
- Available
- Update date
- 11/02/2026
- Dosage form
- Tablet
- Presentation
- Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)
- Company name
- Teva Pharmaceuticals USA, Inc.
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA040422
- Brand name
- ADDERALL
- Generic name
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE
- Manufacturer name
- Teva Pharmaceuticals USA, Inc.
- Product NDC
- 57844-117, 57844-105, 57844-110, 57844-112, 57844-115, 57844-120, 57844-130
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE
- RxCUI
- 541363, 541365, 541878, 541879, 541892, 541894, 577957, 577960, 577961, 577962, 687043, 687045, 1009145, 1009147
- SPL ID
- 79af1dc6-c7cf-41b1-a750-e9b47c2187ff
- SPL set ID
- f22635fe-821d-4cde-aa12-419f8b53db81
- Package NDC
- 57844-105-01, 57844-117-01, 57844-110-01, 57844-112-01, 57844-115-01, 57844-120-01, 57844-130-01
- UNII
- G83415V073, JJ768O327N, O1ZPV620O4, 6DPV8NK46S